Cargando…
Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
Sarcomas are a class of rare malignancies of mesenchymal origin with a heterogeneous histological spectrum. They are classically associated with poor outcomes, especially once metastasized. A path to improving clinical outcomes may be made through modifying the epigenome, where a variety of sarcomas...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992584/ https://www.ncbi.nlm.nih.gov/pubmed/35582536 http://dx.doi.org/10.20517/cdr.2021.88 |